Literature DB >> 25690362

Antimalarial activity of kinase inhibitor, nilotinib, in vitro and in vivo.

Aki Ishiyama1, Masato Iwatsuki1, Rei Hokari2, Masaaki Sawa3, Satoshi Ōmura4, Kazuhiko Otoguro2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25690362     DOI: 10.1038/ja.2015.7

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  31 in total

Review 1.  ATP-site directed inhibitors of cyclin-dependent kinases.

Authors:  N Gray; L Détivaud; C Doerig; L Meijer
Journal:  Curr Med Chem       Date:  1999-09       Impact factor: 4.530

2.  Artemisinin combination therapies and malaria parasite drug resistance: the game is afoot.

Authors:  Steve M Taylor; Jonathan J Juliano
Journal:  J Infect Dis       Date:  2014-03-08       Impact factor: 5.226

3.  A molecular marker of artemisinin-resistant Plasmodium falciparum malaria.

Authors:  Frédéric Ariey; Benoit Witkowski; Chanaki Amaratunga; Johann Beghain; Anne-Claire Langlois; Nimol Khim; Saorin Kim; Valentine Duru; Christiane Bouchier; Laurence Ma; Pharath Lim; Rithea Leang; Socheat Duong; Sokunthea Sreng; Seila Suon; Char Meng Chuor; Denis Mey Bout; Sandie Ménard; William O Rogers; Blaise Genton; Thierry Fandeur; Olivo Miotto; Pascal Ringwald; Jacques Le Bras; Antoine Berry; Jean-Christophe Barale; Rick M Fairhurst; Françoise Benoit-Vical; Odile Mercereau-Puijalon; Didier Ménard
Journal:  Nature       Date:  2013-12-18       Impact factor: 49.962

4.  Potent antimalarial activities of polyether antibiotic, X-206.

Authors:  K Otoguro; A Kohana; C Manabe; A Ishiyama; H Ui; K Shiomi; H Yamada; S Omura
Journal:  J Antibiot (Tokyo)       Date:  2001-08       Impact factor: 2.649

5.  Isolation and expression of a gene specifying a cdc2-like protein kinase from the human malaria parasite Plasmodium falciparum.

Authors:  P B Ross-Macdonald; R Graeser; B Kappes; R Franklin; D H Williamson
Journal:  Eur J Biochem       Date:  1994-03-15

6.  Pfmrk, a MO15-related protein kinase from Plasmodium falciparum. Gene cloning, sequence, stage-specific expression and chromosome localization.

Authors:  J L Li; K J Robson; J L Chen; G A Targett; D A Baker
Journal:  Eur J Biochem       Date:  1996-11-01

Review 7.  Erlotinib: a new therapeutic approach for non-small cell lung cancer.

Authors:  Philip Bonomi
Journal:  Expert Opin Investig Drugs       Date:  2003-08       Impact factor: 6.206

Review 8.  Molecular basis for sunitinib efficacy and future clinical development.

Authors:  Sandrine Faivre; George Demetri; William Sargent; Eric Raymond
Journal:  Nat Rev Drug Discov       Date:  2007-09       Impact factor: 84.694

Review 9.  Targeting the cancer kinome through polypharmacology.

Authors:  Zachary A Knight; Henry Lin; Kevan M Shokat
Journal:  Nat Rev Cancer       Date:  2010-02       Impact factor: 60.716

Review 10.  Protein kinases of the human malaria parasite Plasmodium falciparum: the kinome of a divergent eukaryote.

Authors:  Pauline Ward; Leila Equinet; Jeremy Packer; Christian Doerig
Journal:  BMC Genomics       Date:  2004-10-12       Impact factor: 3.969

View more
  2 in total

1.  Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy.

Authors:  Tariq Hussain; Deming Zhao; Syed Zahid Ali Shah; Naveed Sabir; Jie Wang; Yi Liao; Yinjuan Song; Haodi Dong; Mazhar Hussain Mangi; Jiamin Ni; Lifeng Yang; Xiangmei Zhou
Journal:  Cells       Date:  2019-05-26       Impact factor: 6.600

2.  Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.

Authors:  Ana Carolina C de Sousa; Keletso Maepa; Jill M Combrinck; Timothy J Egan
Journal:  Molecules       Date:  2020-03-29       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.